Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...

Invivyd (IVVD) is an interesting biotech because it has already received emergency use authorization [EUA] from the FDA for its pre-exposure prophylaxis [PrEP] vaccine candidate PEMGARDA [pemivibart] ...

High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...

Nov 23 (Reuters) - Merck & Co Inc (MRK.N), opens new tab has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in ...

Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no ...